Lars von Trier has been diagnosed with Parkinsons disease at the age of 66, per a statement from his representatives. The filmmaker is receiving treatment and will be able to finish his next project, the highly anticipated third season of The Kingdom, but will be keeping a lower public profile in the future. Lars is in good spirits and is being treated for his symptoms and given treatment so he can complete Riget Exodus, the statement said. Continue reading →

Mercks neuroscience portfolio is thin and there hasnt been much in this part of the pharmaceutical giants pipeline since the failure of an Alzheimers disease drug in a pivotal clinical trial five years ago. Biotech company Cerevance has had success discovering and advancing a Parkinsons disease drug candidate and Merck now wants to tap the startups technology to see if it can yield similar results in Alzheimers Continue reading →

Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA. The US Food and Drug Administration (FDA) sent a Complete Response Letter (CRL) regarding the supplemental new drug application (sNDA) for pimavanserin (Nuplazid) for the treatment of hallucinations and delusions associated with Alzheimer disease psychosis (ADP), according to Acadia Pharmaceuticals.1 The CRL indicated that the FDA has completed review of the application and could not approve the sNDA in its present form. The FDA recommended that Acadia conduct an additional trial in ADP Continue reading →

Liz Holroyd with her husband Scott created the White Rock Parkinson Walk and are excited for its triumphant in-person return. (Contributed photo) Liz Holroyd is an advocate for Parkinsons Disease awareness and research after being diagnosed White Rocks Parkinsons SuperWalk will be returning next month, with the creator of the group reminding the city of how crucial it is to bring awareness to the disease and funds to help combat it. Liz Holroyd started the White Rock Walk after going through a really scary time from being diagnosed with Parkinsons Disease in 2010 Continue reading →

BETHESDA, Md., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. Continue reading →

Benskey, M. J., Perez, R. G Continue reading →

You should read the following discussion of our financial condition and results of operations in conjunction with our unaudited interim condensed consolidated financial statements and the related notes and other financial information included elsewhere in this Quarterly Report and the audited financial statements and related notes and management's discussion and analysis of financial condition and results of operations for the year ended December 31, 2021 included in our Annual Report. Continue reading →

New Jersey, United States Parkinsons Disease TreatmentMarket report performs thorough market observation to identify market potential statistics to make an informative decision for the business. Potential customers and their demands are studied in the market analysis to guide industry owners to launch the right products into the market and generate larger revenues. It works as an effective means to forecast market growth and overall sales growth Continue reading →